High performance liquid chromatography method for quantification of the n-phenylpiperazine derivative lassbio-579 in rat plasma
Visualizar/abrir
Data
2007Autor
Abstract
A rapid HPLC analytical method was developed and validated for the determination of the N-phenylpiperazine derivative LASSBio- 579 in plasma rat. Analyses were performed using a C18 column and elution with 20 mM sodium dihydrogen phosphate monohydrate-methanol. The analyte was monitored using a photodiode array detector (257 nm). Calibration curves in spiked plasma were linear over the concentration range of 0.3-8 μg/mL with determination coefficient > 0.99. The lower limit of quantification wa
A rapid HPLC analytical method was developed and validated for the determination of the N-phenylpiperazine derivative LASSBio- 579 in plasma rat. Analyses were performed using a C18 column and elution with 20 mM sodium dihydrogen phosphate monohydrate-methanol. The analyte was monitored using a photodiode array detector (257 nm). Calibration curves in spiked plasma were linear over the concentration range of 0.3-8 μg/mL with determination coefficient > 0.99. The lower limit of quantification was 0.3 μg/mL. The applicability of the HPLC method for pharmacokinetic studies was tested using plasma samples obtained after administration of LASSBio-579 to Wistar rats, showing the specificity of the method.
Coleções
-
Artigos de Periódicos (42138)Ciências da Saúde (11388)
Este item está licenciado na Creative Commons License
